This effect benefits people who struggle with overeating or cravings for high-calorie foods
Therapies based on glucagon-like peptide-1 (GLP-1) reduce rates of cardiovascular and chronic kidney disease in people with type 2 diabetes and/or obesity, with ongoing clinical trials investigating their effects in people with metabolic liver disease, arthritis, and both substance use and neurodegenerative disorders
La perdita di peso, o meglio, il dimagrimento , sono il risultato di una serie di strategie , prevalentemente alimentari ( alimentazione sana ed equilibrata), ma anche pertinenti altri aspetti dello stile di vita, la cui azione combinata fa s che la persona perda tessuto adiposo in eccesso mantenendo invece, o aumentando, la muscolatura (la cosiddetta massa magra)
I love amino club- CARLA2 I love Coffee & Peppers CARLA143 I also love AURUM BIO LABS
Ozempic is also FDA-approved to lower the risk of major cardiovascular events, like heart attack, death, or stroke, in adults with type 2 diabetes and heart disease
Let your care team know if it feels bothersome or doesn't go away